{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:50:04Z","timestamp":1791967804296,"version":"4.3.4"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ajmera Transplant Centre"},{"name":"seed fund"},{"name":"Cell and Engineering Approaches to Preserve and Rejuvenate Organs"},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Collaborative Research and Training Experience (CREATE) program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Relapsing cytomegalovirus DNAemia remains a challenge after organ transplantation. We evaluated longitudinal viral loads and T-cell responses in 62 recipients, of whom 15 relapsed. Week 2 viral loads, but not viral decay slopes or HCMV-specific T-cell responses differed by relapse status, supporting further evaluation of early viral burden.<\/jats:p>","DOI":"10.1093\/ofid\/ofag625","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:01:17Z","timestamp":1790769677000},"source":"Crossref","is-referenced-by-count":0,"title":["Virologic and Exploratory Immunologic Characterization of Relapsing Human Cytomegalovirus (HCMV) DNAemia in Solid Organ Transplant Recipients: A Prospective Observational Cohort Study"],"prefix":"10.1093","volume":"13","author":[{"given":"Golnaz","family":"Amidpour","sequence":"first","affiliation":[{"name":"Ajmera Transplant Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Institute of Medical Science (IMS), University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2225-3706","authenticated-orcid":false,"given":"Poramed","family":"Winichakoon","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University , Chiang Mai ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4273-2207","authenticated-orcid":false,"given":"Ilona","family":"Bahinskaya","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, University Health Network , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Marocco","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, University Health Network , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-1938","authenticated-orcid":false,"given":"Marcelo","family":"Cypel","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Institute of Medical Science (IMS), University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Kumar","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Institute of Medical Science (IMS), University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1751-7159","authenticated-orcid":false,"given":"Atul","family":"Humar","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Institute of Medical Science (IMS), University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-9711","authenticated-orcid":false,"given":"Victor H","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Ajmera Transplant Centre, University Health Network , Toronto, ON ,","place":["Canada"]},{"name":"Institute of Medical Science (IMS), University of Toronto , Toronto, ON ,","place":["Canada"]},{"name":"Department of Laboratory Medicine and Pathobiology (LMP), University of Toronto , Toronto, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026101404164007400_ofag625-B1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"key":"2026101404164007400_ofag625-B2","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(00)02350-3","article-title":"Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation","volume":"355","author":"Emery","year":"2000","journal-title":"Lancet"},{"key":"2026101404164007400_ofag625-B3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1600-6143.2004.00391.x","article-title":"Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+\/R- solid organ transplant recipients","volume":"4","author":"Humar","year":"2004","journal-title":"Am J Transplant"},{"key":"2026101404164007400_ofag625-B4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3851\/IMP3129","article-title":"The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation","volume":"22","author":"Reischig","year":"2017","journal-title":"Antivir Ther"},{"key":"2026101404164007400_ofag625-B5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1600289","article-title":"Impact of viral load kinetics and recurrent cytomegalovirus infection in kidney transplantation","volume":"16","author":"Dobrer","year":"2025","journal-title":"Front Immunol"},{"key":"2026101404164007400_ofag625-B6","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/TP.0000000000001338","article-title":"Recurrence of CMV infection and the effect of prolonged antivirals in organ transplant recipients","volume":"101","author":"Natori","year":"2017","journal-title":"Transplantation"},{"key":"2026101404164007400_ofag625-B7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1086\/514555","article-title":"Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group","volume":"25","author":"Falagas","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2026101404164007400_ofag625-B8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2009.02861.x","article-title":"Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients","volume":"10","author":"Eid","year":"2010","journal-title":"Am J Transplant"},{"key":"2026101404164007400_ofag625-B9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1600-6143.2009.02617.x","article-title":"Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients","volume":"9","author":"Asberg","year":"2009","journal-title":"Am J Transplant"},{"key":"2026101404164007400_ofag625-B10","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/ajt.14347","article-title":"An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplant"},{"key":"2026101404164007400_ofag625-B11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1432-2277.2011.01321.x","article-title":"The risk of cytomegalovirus recurrence after kidney transplantation","volume":"24","author":"Helanter\u00e4","year":"2011","journal-title":"Transpl Int"},{"key":"2026101404164007400_ofag625-B12","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"Asberg","year":"2007","journal-title":"Am J Transplant"},{"key":"2026101404164007400_ofag625-B13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/315242","article-title":"Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation","volume":"181","author":"Sia","year":"2000","journal-title":"J Infect Dis"},{"key":"2026101404164007400_ofag625-B14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/cid\/ciy295","article-title":"Absolute lymphocyte count: a predictor of recurrent cytomegalovirus disease in solid organ transplant recipients","volume":"67","author":"Gardiner","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026101404164007400_ofag625-B15","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14292","article-title":"Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: does recurrent cytomegalovirus DNAemia impact patient survival?","volume":"26","author":"Fern\u00e1ndez-Garc\u00eda","year":"2024","journal-title":"Transpl Infect Dis"},{"key":"2026101404164007400_ofag625-B16","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13189","article-title":"The impact of recurrent cytomegalovirus infection on long-term survival in solid organ transplant recipients","volume":"21","author":"Gardiner","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"2026101404164007400_ofag625-B17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00007890-199901150-00016","article-title":"Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients","volume":"67","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"2026101404164007400_ofag625-B18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.healun.2011.02.017","article-title":"Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial","volume":"30","author":"Finlen Copeland","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2026101404164007400_ofag625-B19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1600-6143.2012.04339.x","article-title":"Late-onset cytomegalovirus (CMV) in lung transplant recipients: can CMV serostatus guide the duration of prophylaxis?","volume":"13","author":"Schoeppler","year":"2013","journal-title":"Am J Transplant"},{"key":"2026101404164007400_ofag625-B20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ajt.2024.01.027","article-title":"Association between cytomegalovirus viremia and long-term outcomes in lung transplant recipients","volume":"24","author":"Kawashima","year":"2024","journal-title":"Am J Transplant"},{"key":"2026101404164007400_ofag625-B21","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/TP.0000000000000549","article-title":"Incidence, risk factors and outcomes of delayed-onset cytomegalovirus disease in a large retrospective cohort of lung transplant recipients","volume":"99","author":"Santos","year":"2015","journal-title":"Transplantation"},{"key":"2026101404164007400_ofag625-B22","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1111\/j.1600-6143.2009.02897.x","article-title":"Cytomegalovirus in solid organ transplant recipients","volume":"9 Suppl 4","author":"Humar","year":"2009","journal-title":"Am J Transplant"},{"key":"2026101404164007400_ofag625-B23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/338143","article-title":"High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy","volume":"185","author":"Limaye","year":"2002","journal-title":"J Infect Dis"},{"key":"2026101404164007400_ofag625-B24","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1600-6143.2004.00505.x","article-title":"Cytomegalovirus and lung transplantation","volume":"4","author":"Zamora","year":"2004","journal-title":"Am J Transplant"},{"key":"2026101404164007400_ofag625-B25","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.athoracsur.2018.10.034","article-title":"Long-term impact of cytomegalovirus serologic status on lung transplantation in the United States","volume":"107","author":"Kurihara","year":"2019","journal-title":"Ann Thorac Surg"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag625\/71561486\/ofag625.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/10\/ofag625\/71561486\/ofag625.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/10\/ofag625\/71561486\/ofag625.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:16:53Z","timestamp":1791965813000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag625\/8859267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag625","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,29]]},"article-number":"ofag625"}}